AYTU Stock Chart

Aytu BioScience is a specialty pharmaceutical company focused on developing and commercializing novel products in the field of urology. Aytu is initially concentrating on hypogonadism, prostate cancer, male infertility, and plans to expand into other urological indications for which there are significant medical needs.
The Company currently markets Natesto (testosterone) nasal gel, the only FDA-approved nasally administered testosterone. Natesto is an androgen indicated for replacement therapy in adult males with a deficiency or absence of endogenous testosterone due to primary hypogonadism (congenital or acquired) or hypogonadotropic hypogonadism.